Bovine ELISA Kits: Choosing the Right Analyte Panel for Cattle Research

How to choose bovine ELISA kits by research question rather than by target — five analyte clusters, a decision matrix, and where species-validated reagents for Bos taurus run out.
Bovine ELISA Kits: Choosing the Right Analyte Panel for Cattle Research
From Biohippo Resources

Choosing bovine ELISA kits is rarely a matter of picking the best kit for one target — it is a matter of deciding which panel of analytes makes your result interpretable at all. Most bovine ELISA kits measure something that means little on its own: a ligand needs its binding protein, an inflammatory marker needs a second marker to separate local from systemic disease, and a metabolic hormone needs its carrier. This note works from the biological question back to the minimum interpretable panel, covers the two constraints that most often break a cattle study — species validation and sample matrix — and states plainly where species-validated reagents for Bos taurus run out.

Why single-analyte bovine ELISA measurements rarely carry a study

A serum activin A concentration is close to uninterpretable without follistatin, because follistatin binds activin with high affinity and the great majority of circulating follistatin is in an activin-bound state.1,2 A total IGF-1 value shifts meaning entirely with binding-protein status and hepatic GH responsiveness, both of which change sharply across the transition period.3 One inflammatory cytokine cannot separate a local intramammary response from a systemic one. The recurring failure in bovine assay design is not picking a poor kit — it is committing to a single analyte where the biology requires a panel, and discovering the gap after collection has closed and the animals have moved on.

Two further constraints are specific to working in cattle rather than in rodents or human samples.

Species validation is unevenly distributed. Coverage is deep for some pathways and effectively absent for others — most conspicuously the reproductive endocrine axis, which is where a great deal of bovine physiology actually happens. Because many of these targets are highly conserved, it is tempting to substitute a human kit and assume cross-reactivity. That assumption is testable, and should be tested rather than made.

Sample matrix is more varied and less controlled. Bovine work routinely generates follicular fluid, uterine flush, milk, and field-collected serum, none of which behave like the bench-collected human plasma most ELISA kits are optimised against. Pre-analytical variance in a herd study frequently exceeds assay variance, which means the collection protocol deserves as much design attention as kit selection.

One structural feature of the species is worth stating, because it shapes what these measurements can be used to claim. Cattle are mono-ovulatory and show distinct follicular waves, so bovine ovarian dynamics are a closer analogue to human physiology than the poly-ovulatory rodent — wave dynamics were characterised in cattle before they were described in women, and no fundamental difference in dominant-follicle selection mechanism has been identified between cows and women.4,5 Bovine tissue is also available fresh and at scale, which is why bovine cartilage, corneal endothelium, and aortic endothelium became standard materials in matrix biology and angiogenesis research. Findings in cattle are therefore frequently proposed as translational, and that proposal stands or falls on how defensible the underlying measurement is.

Three questions to answer before you buy bovine ELISA kits

Before comparing kits, these three questions narrow the field. Work through them in order — the third is the one most often skipped, and the most expensive to skip.

Three questions before choosing bovine ELISA kits: biological question, available sample matrix, and minimum interpretable panel
Figure 1. The three-question filter applied before kit comparison. Question 3 — the minimum interpretable panel — is the one most often skipped, and the only one that cannot be fixed after sample collection has closed. Click to enlarge.
Three questions before choosing bovine ELISA kits, enlarged view
  1. What is the biological question, not the target? “Follicle selection,” “mastitis severity,” “transition-cow energy status,” and “carcass growth” each pull a different analyte set. Naming the question first stops you buying a single marker that cannot be interpreted alone.
  2. What matrix will you actually have? Serum and plasma are the default, but bovine work generates matrices that human assays are rarely validated for — milk, follicular fluid, uterine flush, rumen fluid, saliva. Check the validated sample-type list on the product page before you plan collection, not after.
  3. What is the minimum interpretable panel? Very few analytes mean anything in isolation. A ligand needs its binding protein or its antagonist; an inflammatory marker needs a second marker to separate local from systemic. Decide the panel before you buy the first kit.

Five bovine analyte clusters that map to real research questions

Each cluster below is held together by a shared signalling pathway or a shared physiological process. That is the reason its members get measured together, and the reason a value from one is easier to interpret against a value from another.

Five bovine analyte clusters for ELISA panel design: TGF-beta superfamily, somatotropic and metabolic axis, inflammation and innate immunity, vascular biology, oxidative stress
Figure 2. Five analyte clusters used to build bovine ELISA panels. Clusters are grouped by shared pathway or shared physiological process, not by catalogue category; activin A appears in two clusters because it functions in both. Click to enlarge.
Five bovine analyte clusters for ELISA panel design, enlarged view

1. TGF-β superfamily and SMAD signalling — folliculogenesis, bone, muscle

The largest and most mechanistically coherent cluster. Activins and TGF-βs signal through SMAD2/3; BMPs and most GDFs signal through SMAD1/5/8. The balance between those two arms is a central control mechanism in ovarian follicle selection, in chondrocyte and osteoblast differentiation, and in skeletal muscle growth.

Two relationships change how you interpret a number. First, activin A and myostatin (GDF8) share type II receptors (ActRIIA / ActRIIB), and follistatin binds activin with highest affinity but also binds myostatin and several BMPs — structural work shows follistatin encircling activin and blocking both type I and type II receptor sites, so these are not independent readouts.6,7 Second, BMP and activin signals are frequently antagonistic within the same follicle, which means a rise in one is only interpretable against the other. The timing is tight: in cattle, differential FSH dependence and the associated changes in free activin, inhibin precursors and bioavailable IGF appear within roughly 33 h of the FSH peak, before diameter deviation is visible.8 Intrafollicular activin A also differs sharply with oestrogenic status — it is highest in oestrogen-inactive follicles.9 Sampling windows matter as much as the choice of analyte.

Reach for this cluster when you are working on ovarian follicular dynamics, oocyte and embryo culture, cartilage or bone biology, or muscle and carcass phenotype. Measure at least two members across the SMAD2/3 and SMAD1/5/8 arms rather than one in isolation.

2. Somatotropic and metabolic axis — transition cow, energy balance, growth

The period around calving is the highest-risk window in a dairy cow’s year: intake falls, milk demand rises, and the resulting negative energy balance uncouples growth hormone from IGF-1 in the liver. Hepatic GH receptor 1A abundance falls, the liver becomes refractory to GH, and circulating IGF-1 drops even as GH rises — insulin infusion restores GHR 1A and hepatic IGF-1 expression, confirming the uncoupling is metabolic rather than pituitary.3 Severe negative energy balance also lowers hepatic transcripts for IGFBP-3, -4, -5 and -6 while raising IGFBP-2, so binding-protein status moves independently of total IGF-1.10

IGF-1 is the anchor analyte, but the free-versus-bound distinction matters — which is why IGFBP-3 belongs in the same panel rather than being an optional extra. Adipokines and adipose-derived signals extend the picture into body-condition and lipid-mobilisation phenotypes.

Reach for this cluster when you are studying the transition period, energy balance, body-condition phenotypes, or growth and feed efficiency. Pair IGF-1 with its binding protein; a total IGF-1 number alone is hard to interpret across changing metabolic states.

3. Inflammation and innate immunity — mastitis, metritis, respiratory disease

Mastitis and bovine respiratory disease are the two costliest health problems in dairy and feedlot systems respectively, and both are read out through the innate immune response. The practical challenge is separating local from systemic inflammation, which requires more than one marker and usually more than one matrix.

Cytokines give the mechanistic signal; antimicrobial peptides and damage-associated molecules give severity and tissue-injury context. Note that activin A also belongs here. Following an acute inflammatory challenge it is released rapidly into the circulation, slightly ahead of TNF-α and before IL-6, and blocking it with follistatin alters the subsequent cytokine profile and reduces mortality in endotoxaemia — so it behaves as a component of the cascade rather than a downstream marker of it.11,12 This has been characterised in the ewe as well as in rodent models, which is directly relevant if you are extrapolating to ruminants.13 It is part of why activin A appears in two clusters in this note.

Reach for this cluster when you are running intramammary or intrauterine challenge studies, BRD pathogenesis work, vaccine response, or welfare and stress phenotyping. Combine at least one pro-inflammatory cytokine with one tissue-injury or antimicrobial marker.

4. Vascular biology and angiogenesis — follicle, corpus luteum, placenta

Easy to overlook, and central to bovine reproduction. Dominant follicle selection, corpus luteum formation and regression, and placentome development are all fundamentally angiogenic events. VEGF isoform expression in granulosa cells is stage-dependent: post-selection follicles with high intrafollicular oestradiol express more VEGF120, VEGF164 and Flk-1 than pre-selection follicles, and FSH plus low oestradiol stimulates that expression in vitro.14 VEGF also rises through follicle growth while the anti-angiogenic thrombospondins fall, an inverse pattern that makes the balance more informative than either factor alone.15 This cluster is therefore a reproductive panel as much as a cardiovascular one.

It is also where the classical bovine cell-culture heritage sits: bovine aortic and corneal endothelial cells were foundational to angiogenesis research, and remain in use.

Reach for this cluster when you are studying follicular or luteal vascularisation, placental development, endothelial function, or coagulation and vascular injury. The ANG-1 : ANG-2 ratio carries more information than either alone.

5. Oxidative stress and tissue injury — metabolic stress, heat stress, organ damage

Oxidative stress markers rarely carry a study on their own, but they are the standard supporting layer for transition-cow, heat-stress, and toxicology work — contexts where the primary insult is metabolic rather than infectious. Tissue-specific enzymes add organ-level resolution when you need to know where damage occurred.

Reach for this cluster when you need to characterise metabolic or heat stress, or localise tissue injury alongside a primary phenotype. Treat these as context, not as the primary endpoint.

Where species-validated bovine reagents run out

Being straightforward about the gaps saves everyone a failed experiment. Three areas deserve explicit warning.

Cross-reactive with bovine versus species-validated bovine ELISA kits: standard curve, matrix validation and precision data for Bos taurus
Figure 3. Cross-reactivity is not validation. A species-validated bovine ELISA kit has its standard curve, matrix compatibility and precision data generated in cattle; a human kit assumed to cross-react has none of these in your species. Click to enlarge.
Cross-reactive versus species-validated bovine ELISA kits, enlarged view

The bovine reproductive endocrine axis is thinly served

Anyone working on bovine folliculogenesis will want inhibin A and B, follistatin, AMH, FSH, LH, progesterone, and oestradiol. AMH in particular has become the standard endocrine marker of the gonadotropin-responsive follicle pool in cattle: antral follicle count and serum AMH both reliably predict the number of morphologically healthy follicles and oocytes in the ovaries of young adult cattle.16,17 Species-validated bovine kits for these targets are scarce across the market, and the BioHippo catalog currently reflects that — the gonadotropin-releasing hormone receptor is the main reproductive-endocrinology item stocked. If your design depends on this axis, treat sourcing as a project step rather than an assumption, and talk to a specialist about custom or alternative-species options before finalising the protocol.

Activin A cannot be interpreted without follistatin

A large fraction of circulating activin A is bound by follistatin, and assays in this family can also cross-react with inhibin A, which shares the βA subunit. This is a long-standing, well-documented problem: reliable activin measurement in serum and in follicular fluid has required dissociating agents to remove follistatin interference, and published two-site assays report “total” rather than free activin A for exactly this reason.1,9 Confirm what the specific kit’s datasheet says about follistatin interference and inhibin cross-reactivity before you design around a total-activin readout — this is a question for the datasheet and, if unanswered there, for the supplier.

“Cross-reactive with bovine” is not the same as bovine-validated

Because many of these targets are highly conserved across mammals, some laboratories run human kits on bovine samples on the assumption of cross-reactivity. Sometimes this works. It is not, however, the same as a kit whose standard curve, matrix validation, and precision data were generated in the target species. The difference is measurable: a ruminant-specific AMH immunoassay returned plasma AMH values roughly 44-fold higher than a human-derived assay across the same 40 cow plasma samples, and correlated better with the number of embryos recovered after superovulation.18 Where a species-validated option exists, the interpretive advantage is real.

Pre-analytical discipline. Bovine field sampling is harder to standardise than benchtop human work, and pre-analytical variance frequently exceeds assay variance. Aliquot before freezing to avoid repeated freeze–thaw, hold long-term storage at −80 °C, and keep collection, processing time, and anticoagulant consistent across every animal and timepoint in the study. Where a kit specifies a particular plasma anticoagulant, that specification is not interchangeable.

Decision matrix: research question to bovine ELISA panel

A shortcut from the study you are running to the panel that supports it.

If your question is… Anchor cluster Minimum interpretable panel
Which follicle becomes dominant, and why TGF-β superfamily + vascular Activin A with a BMP, plus VEGFA and ANG-1/ANG-2
Oocyte competence and embryo culture optimisation TGF-β superfamily Activin A, a BMP, and IGF-1 in conditioned media
Why cows fail to resume cycling postpartum Metabolic + inflammation IGF-1 with IGFBP-3, plus an inflammatory marker
Severity and resolution of intramammary infection Inflammation A cytokine (IFN-γ or IL-17A) with β-defensin 1 or HMGB1
Bovine respiratory disease pathogenesis Inflammation + respiratory Surfactant proteins with IFN-γ and a tissue-injury marker
Muscle growth, carcass traits, feed efficiency TGF-β superfamily + metabolic GDF8/myostatin with IGF-1 and IGFBP-3
Heat stress or metabolic stress phenotyping Oxidative stress + metabolic Catalase or ROMO1 alongside IGF-1
Placental development and pregnancy loss Vascular + TGF-β superfamily VEGFA, ANG-1/ANG-2, and a TGF-β isoform

Panels here are starting points for design, not validated protocols. Confirm sample-type compatibility and working range on each product page before committing to a collection plan.

Running one target across bovine, human and rodent samples

Bovine studies frequently sit alongside rodent or human work — a mechanism established in mice and tested in cattle, or a cattle finding proposed as a human model. That design only holds together if the same analyte is measured on a comparable platform in every species, rather than stitching together three vendors’ assays with three different antibody pairs and three different standards.

Activin A is a useful worked example: the same PicoKine® sandwich format is available across bovine, human, mouse, rat, porcine, rabbit, and non-human primate reactivity. Keeping the platform constant across species removes one large source of between-group variance from a comparative design — and makes the cross-species claim considerably easier to defend.

Design note: matching the platform does not make absolute concentrations directly comparable between species — standards, immunogens, and matrix effects still differ. What it buys you is consistent methodology and comparable relative change, which is usually the claim you actually want to make.

Bovine ELISA kits by analyte cluster

All kits below are species-validated for Bos taurus. Confirm assay format, sensitivity, working range, and validated sample types on each product page before purchase. For the full catalogue, browse all ELISA kits or search bovine ELISA kits.

TGF-β superfamily & SMAD signalling

Folliculogenesis · bone & cartilage · muscle and carcass traits

Somatotropic & metabolic axis

Transition cow · energy balance · growth efficiency

Inflammation & innate immunity

Mastitis · metritis · respiratory disease · welfare

Respiratory & surfactant

Bovine respiratory disease · lung injury

Vascular biology & angiogenesis

Follicular & luteal vascularisation · placentation · endothelial function

Oxidative stress & tissue injury

Metabolic & heat stress · organ-level damage

Neuroscience & endocrine

Neurotrophins · reproductive endocrine signalling

High-volume & custom assay development

Matched antibody pairs for build-your-own and automated formats

Cross-species comparative work — Activin A

Same PicoKine® sandwich format across species for comparative designs

Not seeing your target? Species coverage in the reproductive endocrine axis is limited across the market. Request a quote or talk to a specialist about sourcing or custom assay development before finalising your protocol.

Frequently asked questions about bovine ELISA kits

Can I use a human ELISA kit on bovine samples?

Sometimes, for highly conserved targets, and some laboratories do. But cross-reactivity is not validation: the standard curve, matrix compatibility, and precision data were generated in a different species, so absolute concentrations may be systematically off and low-abundance samples may fall below a curve that was never optimised for your matrix. The ruminant-specific AMH comparison above shows how large that offset can be.18 If a species-validated bovine kit exists for your target, it is the defensible choice. If one does not, run a spike-recovery and linearity-of-dilution check in your own matrix before you trust the numbers.

My matrix is follicular fluid or milk. Will a serum-validated bovine ELISA kit work?

Do not assume so. Follicular fluid and milk are compositionally very different from serum — protein content, lipid content, and interfering factors all differ — and a kit validated for serum, plasma, and culture supernatant has not been tested against them. Check the product page’s validated sample-type list first. If your matrix is not listed, validate it yourself with spike-recovery and dilutional linearity, and report that you did.

Why does one analyte appear in more than one cluster?

Because the biology is genuinely shared. Activin A is a TGF-β superfamily ligand controlling follicle development and an early acute-phase inflammatory mediator.11 IGF-1 is metabolic and growth-related. Placing a target in one box and one box only would misrepresent how it behaves. This is also why the interpretation of a single marker depends so heavily on what you measured alongside it.

My samples are near the bottom of the standard curve. What are my options?

Run a pilot dilution series first to find where your samples actually sit, rather than guessing. If they genuinely fall below the working range, the options are to reduce dilution, concentrate the sample, or move to a higher-sensitivity assay format. Reporting a large fraction of samples as “below detection” collapses exactly the biological variation you set out to measure. The high-sensitivity ELISA kit range lists the available formats.

I need a large number of samples across many timepoints. Is a kit still the right format?

At high volume, matched antibody pairs are usually more economical and give you control over plate format, coating conditions, and automation. The trade-off is that you take on assay development and validation yourself. For a single study or a pilot, a ready-made kit is faster and more reproducible; for a multi-year programme running thousands of wells on the same target, DIY antibody pairs are worth costing out.

References

  1. McFarlane JR, Foulds LM, Pisciotta A, Robertson DM, de Kretser DM. Measurement of activin in biological fluids by radioimmunoassay, utilizing dissociating agents to remove the interference of follistatin. Eur J Endocrinol. 1996;134(4):481–489. PMID 8640301 · DOI
  2. McConnell DS, Wang Q, Sluss PM, Bolf N, Khoury RH, Schneyer AL, et al. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab. 1998;83(3):851–858. PMID 9506739 · DOI
  3. Butler ST, Marr AL, Pelton SH, Radcliff RP, Lucy MC, Butler WR. Insulin restores GH responsiveness during lactation-induced negative energy balance in dairy cattle: effects on expression of IGF-I and GH receptor 1A. J Endocrinol. 2003;176(2):205–217. PMID 12553869 · DOI
  4. Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003;69(3):1023–1031. PMID 12748128 · DOI
  5. Mihm M, Evans ACO. Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women. Reprod Domest Anim. 2008;43(Suppl 2):48–56. PMID 18638104 · DOI
  6. Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell. 2005;9(4):535–543. PMID 16198295 · DOI
  7. Harrington AE, Morris-Triggs SA, Ruotolo BT, Robinson CV, Ohnuma S, Hyvönen M. Structural basis for the inhibition of activin signalling by follistatin. EMBO J. 2006;25(5):1035–1045. PMID 16482217 · DOI
  8. Mihm M, Austin EJ. The final stages of dominant follicle selection in cattle. Domest Anim Endocrinol. 2002;23(1-2):155–166. PMID 12142234 · DOI
  9. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of ‘total’ activin-A concentrations in serum and follicular fluid. J Endocrinol. 1996;148(2):267–279. PMID 8699141 · DOI
  10. Fenwick MA, Fitzpatrick R, Kenny DA, Diskin MG, Patton J, Murphy JJ, Wathes DC. Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. Domest Anim Endocrinol. 2008;34(1):31–44. PMID 17137745 · DOI
  11. Jones KL, de Kretser DM, Patella S, Phillips DJ. Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol. 2004;225(1-2):119–125. PMID 15451576 · DOI
  12. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA. 2007;104(41):16239–16244. PMID 17911255 · DOI
  13. Jones KL, de Kretser DM, Clarke IJ, Scheerlinck JP, Phillips DJ. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. J Endocrinol. 2004;182(1):69–80. PMID 15225132 · DOI
  14. Shimizu T, Jayawardana BC, Tetsuka M, Miyamoto A. Differential effect of follicle-stimulating hormone and estradiol on expressions of VEGF120, VEGF164 and their receptors in bovine granulosa cells. J Reprod Dev. 2007;53(1):105–112. PMID 17043385 · DOI
  15. Greenaway J, Gentry PA, Feige JJ, LaMarre J, Petrik JJ. Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development. Biol Reprod. 2005;72(5):1071–1078. PMID 15616224 · DOI
  16. Ireland JLH, Scheetz D, Jimenez-Krassel F, Themmen APN, Ward F, Lonergan P, et al. Antral follicle count reliably predicts number of morphologically healthy oocytes and follicles in ovaries of young adult cattle. Biol Reprod. 2008;79(6):1219–1225. PMID 18768912 · DOI
  17. Monniaux D, di Clemente N, Touzé JL, Belville C, Rico C, Bontoux M, et al. Intrafollicular steroids and anti-Müllerian hormone during normal and cystic ovarian follicular development in the cow. Biol Reprod. 2008;79(2):387–396. PMID 18448844 · DOI
  18. Arouche N, Picard JY, Monniaux D, Jamin SP, Vigier B, Josso N, et al. The BOC ELISA, a ruminant-specific AMH immunoassay, improves the determination of plasma AMH concentration and its correlation with embryo production in cattle. Theriogenology. 2015;84(8):1397–1404. PMID 26298408 · DOI

Reference metadata verified against PubMed. Cluster groupings reflect shared signalling pathways and shared physiological processes; they are an aid to experimental design, not validated protocols. Suggested panels are starting points and have not been validated as multiplex assays. Confirm assay format, sensitivity, working range, validated sample types, and intended-use statement on each product page and datasheet before purchase. Species-validated reagent availability in the bovine reproductive endocrine axis is limited across the market and subject to change.